Neuropeptides in developmental tumors of the central and peripheral nervous system

Annals of the New York Academy of Sciences

Volumn 865, Issue , 1998, Pages 420-426

  Frühwald, Michael C ^a,b   O'Dorisio, M Sue ^a,c   Cottingham, Sandra L ^a,d   Qualman, Stephen J ^a   O'Dorisio, Thomas M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d SPECTRUM HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE;

CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CONFERENCE PAPER; HUMAN; HUMAN TISSUE; NERVOUS SYSTEM TUMOR;

EID: 0032434173     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11208.x     Document Type: Conference Paper

References (30)

1. O'Dorisio, M. & T. O'Dorisio. 1993. Neural crest tumors: Rationale for somatostatin and its analogs in diagnosis and therapy. In Endocrine Tumors. E. Mazzaferri & N. Jamaan, Eds.: 531-542. Blackwell Scientific Publications. Cambridge.
2. O'Dorisio, M. S., F. Chen, T. M. O'Dorisio, D. Wray & S. Qualman. 1994. Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth Diff. 5: 1-8.
3. Rorke, L. B, J. Q. Trojanowski, V. M. Lee et al. 1997. Primitive neuroectodermal tumors of the central nervous system. Brain Pathol. 7: 765-784.
4. Qualman, S. J., M. S. O'Dorisio, D. J. Fleshman, J. Labanowski, H. Shimada & T. M. O'Dorisio. 1992. Neuroblastoma: Correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 70: 2005-2012.
5. O'Dorisio, T. M., H. S. Mekhjian, E. C. Ellison, M. S. O'Dorisio, T. S. Gaginella & E. A. Woltering. 1987. Role of peptide radioimmunoassay in understanding peptide-peptide interactions and clinical expression of gastroenteropancreatic endocrine tumors. Am. J. Med. 82: 60-67.
6. Burton, K. 1972. Determination of DNA concentration with diphenylamine. Methods Enzymol. 7: 163-167.
7. Bailey, P. & H. Cushing. 1925. Medulloblastoma cerebelli: A common type of midcerebellar glioma of childhood. Arch. Neurol. Psychiatry 14: 192-224.
8. Gould, V. E., D. S. Jansson, W. M. Molenaar et al. 1990. Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins. Lab. Invest. 62: 498.
9. Hennig, I. M., J. A. Laissue, U. Horisberger & J-C. Reubi. 1995. Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int. J. Cancer 61:786-792.
10. Allen, J. M., N. R. Hoyle, J. C. Yeats, M. A. Ghatei, D. G. Thomas & S. R. Bloom. 1985. Neuropeptides in neurological tumours. J. Neurooncol. 3: 197-202.
11. Bateman, D. E., J. R. McDermott, R. H. Perry, R. Dimaline, J. A. Biggins & J. A. Edwardson. 1986. Neuropeptides in gliomas: identification of somatostatin 14 in a medulloblastoma. J. Neurol. Neurosurg. Psych. 49: 1074-1076.
12. Laquerriere, A., B. Leroux, B. Gonzalez, C. Bodenant, J. Tayot & H. Vaudry. 1992. Somatostatin receptors in the human cerebellum during development. Brain Res. 573: 251-259.
13. Müller, H. L., M. C. Frühwald, M. Scheubeck et al. 1997. A possible role for somatostatin receptor (sstr) scintigraphy in the follow-up of children with medulloblastoma (MB). J. Neurooncol. (In press.)
14. Kogner, P., O. Bjork & E. Theodorsson. 1993. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts. Med. Pediatr. Oncol. 21: 317-322.
15. Van Valen, F., W. Winkelmann & H. Jurgens. 1992. Expression of functional Y1 receptors for neuropeptide Y in human Ewing's sarcoma cell lines. J. Cancer Res. Clin. Oncol. 118: 529-536.
16. Inui, A., K. Sano, M. Miura et al. 1992. Evidence for further heterogeneity of the receptors for neuropeptide-Y and peptide- W in tumor cell lines derived from neural crest. Endocrinology 131: 2090-2096.
17. Reubi, J., W. Lang, R. Maurer, J. Koper & S. Lamberts. 1987. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res. 47: 5758-5764.
18. Moody, T. W., S. Mahmoud, J. Staley et al 1989. Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide. J. Mol. Neurosci. 1: 235-242.
19. Sharif, T. R., W. Luo & M. Sharif. 1997. Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway. Mol. Cell Endocrinol. 13: 119-30.
20. Reinecke, M. 1985. Neurotensin: Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role. Prog. Histochem. Cytochem. 16: 1-172.
21. O'Dorisio, T. M., B. A. Howe, D. S. Hill, J. Obermeyer & S. Cataland. 1987. Vasoactive intestinal peptide (VIP) and neurotensin radioimmunoassays. J. Clin. Immunoassay 10: 85-90.
22. O'Dorisio, M. S., D. J. Fleshman, S. J. Qualman & T. M. O'Dorisio. 1992. Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma. Regul. Pept. 37: 213-226.
23. Giangaspero, F., P. C. Burger, D. A. Budwit, L. Usellini & A. M. Mancini. 1985. Regulatory peptides in neuronal neoplasms of the central nervous system. Clin. Neuropathol. 4: 111-115.
24. Vertongen, P., I. Camby, F. Darro, R. Kiss & P. Robberecht. 1996. VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor. Neuropeptides 30: 491-496.
25. Moody, T. W., J. Leyton, I. Gozes et al. 1997. VIP receptor antagonists inhibit the growth of glioblastoma cells. In Proceedings of the Society for Neuroscience (27th Annual Mtg.): 2239(Abstract).
26. Albers, A. R. & M. S. O'Dorisio. 1996. Clinical use of somatostatin analogues in paediatric oncology. Digestion 57(Suppl. 1): 38-41.
27. Virgolini, I., M. Raderer, A. Kurtaran et al. 1994. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N. Engl. J. Med. 331: 1116-1121.
28. Breeman, W. A., M. P. Van Hagen, H. A. Visser-Wisselaar et al. 1996. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1] substance P. J. Nucl. Med. 37: 108-117.
29. Van Hagen, P. M., W. A. P. Breeman, J. C. Reubi et al. 1996. Visualization of the thymus by substance P receptor scintigraphy in man. Eur. J. Nucl. Med. 23: 1508-1513.
30. 1]octreotide: A case history. Ann. N.Y. Acad. Sci. 733: 496-506.